NPTX2, which was decreased in ALS in our study, is involved in mediating excitatory neurotransmission and has been reported to be involved in various diseases such as Parkinson’s disease (PD), ischemia, Alzheimer’s disease (AD), and frontotemporal dementia [63]. This evidence concerns the gene NPTX2 and Alzheimer disease.